Wealthcare Advisory Partners LLC Invests $218,000 in HCA Healthcare, Inc. $HCA

Wealthcare Advisory Partners LLC acquired a new position in HCA Healthcare, Inc. (NYSE:HCA) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 570 shares of the company’s stock, valued at approximately $218,000.

A number of other institutional investors have also recently made changes to their positions in the business. ORG Partners LLC raised its stake in HCA Healthcare by 27.9% in the 2nd quarter. ORG Partners LLC now owns 142 shares of the company’s stock worth $55,000 after acquiring an additional 31 shares during the last quarter. Avantax Advisory Services Inc. raised its stake in HCA Healthcare by 0.4% in the 1st quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company’s stock worth $2,791,000 after acquiring an additional 32 shares during the last quarter. Glenview Trust co raised its stake in HCA Healthcare by 2.3% in the 1st quarter. Glenview Trust co now owns 1,451 shares of the company’s stock worth $501,000 after acquiring an additional 32 shares during the last quarter. Horizon Investments LLC raised its stake in HCA Healthcare by 1.1% in the 1st quarter. Horizon Investments LLC now owns 3,175 shares of the company’s stock worth $1,097,000 after acquiring an additional 33 shares during the last quarter. Finally, Sivia Capital Partners LLC raised its stake in HCA Healthcare by 5.5% in the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after acquiring an additional 33 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the company’s stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the transaction, the executive vice president directly owned 31,503 shares in the company, valued at $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.30% of the stock is owned by company insiders.

HCA Healthcare Stock Performance

HCA opened at $414.73 on Friday. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $439.01. The stock has a market capitalization of $97.04 billion, a PE ratio of 17.43, a P/E/G ratio of 1.32 and a beta of 1.40. The business’s 50 day moving average price is $405.12 and its 200 day moving average price is $375.58.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping analysts’ consensus estimates of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company had revenue of $18.61 billion for the quarter, compared to analysts’ expectations of $18.49 billion. During the same period in the prior year, the firm earned $5.50 earnings per share. The firm’s revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th were paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date was Tuesday, September 16th. HCA Healthcare’s dividend payout ratio is 12.11%.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the company. Wolfe Research lowered HCA Healthcare from an “outperform” rating to a “peer perform” rating in a research note on Monday, July 28th. Bank of America lifted their price target on HCA Healthcare from $375.00 to $410.00 and gave the company a “neutral” rating in a research note on Wednesday, September 10th. UBS Group set a $465.00 price target on HCA Healthcare in a research note on Wednesday. Morgan Stanley cut their price target on HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating for the company in a research note on Monday, July 28th. Finally, Robert W. Baird boosted their price objective on HCA Healthcare from $380.00 to $423.00 and gave the stock a “neutral” rating in a research note on Thursday, August 14th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $422.31.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.